• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAC 22/01/19 8 1.0K
22/01/19 Last post  Lgalp65 Comments Created with Sketch.  8  Views Created with Sketch.  1.0K 
RAC 22/01/19 0 128
22/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  128 
RAC
2019 SP
21/01/19 25 6.3K
21/01/19 Last post  EddyG Comments Created with Sketch.  25  Views Created with Sketch.  6.3K 
RAC
5 Million Shares bought by Insider
15/01/19 21 6.2K
15/01/19 Last post  mcexplorer Comments Created with Sketch.  21  Views Created with Sketch.  6.2K 
RAC
Mcap $6.7 M / Big EFFECTIVE Cancer Drug in P3 (MKT Size ~$500M+) =20+BAGGER
15/01/19 28 4.9K
15/01/19 Last post  Blockbuster Comments Created with Sketch.  28  Views Created with Sketch.  4.9K 
RAC
Priority Review Voucher
14/01/19 0 141
14/01/19 Last post  EddyG Comments Created with Sketch.  0  Views Created with Sketch.  141 
RAC 08/01/19 7 1.5K
08/01/19 Last post  Tez1 Comments Created with Sketch.  7  Views Created with Sketch.  1.5K 
RAC
Currency exposure
03/01/19 0 194
03/01/19 Last post  EddyG Comments Created with Sketch.  0  Views Created with Sketch.  194 
RAC 31/12/18 0 274
31/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  274 
RAC
News: RAC Race Oncology Announces Agreement With Truemed For Bisantrene NPP In Israel
31/12/18 12 2.5K
31/12/18 Last post  Blockbuster Comments Created with Sketch.  12  Views Created with Sketch.  2.5K 
RAC 24/12/18 0 270
24/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  270 
RAC 24/12/18 0 206
24/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  206 
RAC 24/12/18 0 203
24/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  203 
RAC 24/12/18 0 192
24/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  192 
RAC 21/12/18 0 204
21/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  204 
RAC 21/12/18 0 206
21/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  206 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Race appoints leading haematologist to support Bisantrene
22 Jan 09:30
 
Appendix 3B
22 Jan 09:29
 
Change of Director's Interest Notice-Dr William Garner
07 Jan 17:09
 
Change of Director's Interest Notice-Dr William Garner
31 Dec 12:56
 
Change in substantial holding
24 Dec 15:30
 
Change in Director's Interest Notice-Peter Molloy
24 Dec 15:29
 
View More arrow Created with Sketch.
(20min delay)
Last
9.0¢
Change
-0.00(1.10%)
Mkt cap $7.938M
Open High Low Value Volume
9.9¢ 9.9¢ 9.0¢ $6.133K 65.53K

Buyers (Bids)

No. Vol. Price($)
1 1622 9.0¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 40000 1
Last update - 15.49pm 22/01/2019 (20 minute delay) ?
(live)
Last
9.5¢
  Change
-0.00 ( 5.56 %)
Open High   Low Volume
9.5¢ 9.5¢   9.5¢ 25557
Last updated 14.59pm 22/01/2019 (live) ?
RAC (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.